The panel included eight lung cancer cell lines, six of which were tested with siRNA silencing SNRPD2 before, and 17 cell lines representing cancers originating from the skin, pancreas, esophagus, colon, breast, and prostate. Here, SNRPD2 is linked to lung cancer.